Our mission

Discover, develop, and commercialize a new class of RNA therapies informed by human genetics and disease biology to improve the lives of patients with debilitating and life-threatening diseases.

landing_page_hero

Our vision

Create transformative genetic medicines for diseases with high prevalence.

Meet our team

Ram Aiyar, Ph.D., MBA

Read More >

Ram Aiyar, Ph.D., MBA

Chief Executive Officer & President
Kemi Olugemo, M.D., FAAN

Read More >

Kemi Olugemo, M.D., FAAN

Chief Medical Officer
Vineet Agarwal, MBA

Read More >

Vineet Agarwal, MBA

Chief Financial Officer
Todd Chappell, MBA

Read More >

Todd Chappell, MBA

Chief Operating Officer
Jeffrey M. Cerio, Pharm.D., J.D.

Read More >

Jeffrey M. Cerio, Pharm.D., J.D.

SVP, General Counsel
Stephanie Engels

Read More >

Stephanie Engels

SVP, People and Culture
Venkat Krishnamurthy, Ph.D.

Read More >

Venkat Krishnamurthy, Ph.D.

SVP, Head of Platform